Serious game as a therapeutic tool in psychiatry: A systematic review | Le serious game : applications thérapeutiques en psychiatrie

T. Fovet, J.-A. Micoulaud-Franchi, G. Vaiva, P. Thomas, R. Jardri, A. Amad
L'Encéphale. 2016-10-01; 42(5): 463-469
DOI: 10.1016/j.encep.2016.02.008

Lire sur PubMed

1. Encephale. 2016 Oct;42(5):463-469. doi: 10.1016/j.encep.2016.02.008. Epub 2016
Mar 24.

[Serious game as a therapeutic tool in psychiatry: A systematic review].

[Article in French]

Fovet T(1), Micoulaud-Franchi JA(2), Vaiva G(3), Thomas P(3), Jardri R(3), Amad

Author information:
(1)UMR9193-PsychiC-SCALab, pôle de psychiatrie, CNRS, université de Lille, CHU de
Lille, 59000 Lille, France. Electronic address: .
(2)Unité de neurophysiologie et psychophysiologie, pôle de psychiatrie
universitaire, CHU Sainte-Marguerite, 270, boulevard Sainte-Marguerite, 13009
Marseille, France; Laboratoire de neurosciences cognitives (LNC), UMR CNRS 7291,
31 Aix-Marseille université, site Saint-Charles, 3, place Victor-Hugo, 13331
Marseille cedex 3, France.
(3)UMR9193-PsychiC-SCALab, pôle de psychiatrie, CNRS, université de Lille, CHU de
Lille, 59000 Lille, France.

CONTEXT: The growing field of new technologies offers new ways to tackle
psychiatric disorders (e.g. virtual reality therapy, neurofeedback, etc.).
Serious games (SG) are computer applications combining serious aspects with the
fun side of video games. This kind of new media could find applications to treat
psychiatric disorders.
OBJECTIVE: This paper summarizes available data in the literature about
therapeutic interventions using SG in psychiatry.
METHOD: A Medline search was conducted in May 2014 using the following Medical
Subject Headings (MESH) terms: « video games », « mental disorders », and
« psychotherapy ».
RESULTS: Only 10 relevant references were identified according to our inclusion
criteria. These studies show that SG are very interesting tools to improve the
management of psychiatric disorders. However, only low-level evidence is
available to support treatment with SG in patients suffering from psychiatric
disorders. Indeed, randomized controlled trials are rare in this field of
CONCLUSION: SG provide promising therapeutic innovations for the management of
psychiatric disorders. Moreover, they could easily be developed in accordance
with current dimensional approaches. Finally, major issues to facilitate the
implementation of future work on SG in psychiatry are discussed.

Copyright © 2016 L’Encéphale, Paris. Published by Elsevier Masson SAS. All rights

DOI: 10.1016/j.encep.2016.02.008
PMID: 27017317 [Indexed for MEDLINE]

Auteurs Bordeaux Neurocampus